journal article·2008-03

Supercritical CO2 processing of polymers for the production of materials with applications in tissue engineering and drug delivery

Ana M. López-Periago, Arlette Vega, Pascale Subra, Anna Argemí, Javier Saurina, Carlos A. García-González, Concepcion Domingo

Journal of Materials Science· Volume 43· Issue 6
Publisher page

Abstract

Supercritical carbon dioxide (SCCO2) was used for the preparation of foamed sponges and intermingled fibers of biopolymers with potential applications in tissue engineering and drug delivery. The work was focused on the processing of both biodegradable polylactic acid (l-PLA) and non-biodegradable polymethylmethacrylate (PMMA) homopolymers. Monolithic porous sponges of amorphous PMMA were prepared using SCCO2 as a porogen agent by simple swelling and foaming. Under similar experimental conditions, l-PLA was crystallized. The study also addresses the impregnation of biopolymers with an active agent dispersed in SCCO2. The drug used for impregnation was triflusal, a platelet antiaggregant inhibitor for thrombogenic cardiovascular diseases. Foaming often leads to a closed pore structure after depressurization which is disadvantageous for 3D scaffolds as it does not fulfill the requirement of interconnectivity necessary for cell migration. To overcome these drawbacks, fibers forming macroporous structures were prepared using a semicontinuous antisolvent (SAS) technique.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Polymer Foaming and Composites · Carbon dioxide utilization in catalysis · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Hutmacher DW (2000) Biomaterials 21:252910.1016/S0142-9612(00)00121-6 ↗
2. Burg KJL, Porter S, Kellam JF (2000) Biomaterials 21:234710.1016/S0142-9612(00)00102-2 ↗
3. Shin H, Jo S, Mikos AG (2003) Biomaterials 24:435310.1016/S0142-9612(03)00339-9 ↗
4. Liu X, Ma PX (2004) Ann Biomed Eng 32(3):47710.1023/B:ABME.0000017544.36001.8e ↗
5. Whang K, Thomas CH, Healy KE, Nuber G (1995) Polymer 36:83710.1016/0032-3861(95)93115-3 ↗
6. Zhang Y, Lim CT, Ramakrishna S, Huang Z-M (2005) J Mater Sci Mater Med 16:93310.1007/s10856-005-4428-x ↗
7. Tuzlakoglu K, Bolgen N, Salgado AJ, Gomes ME, Piskin E, Reis RL (2005) J Mater Sci Mater Med 16:109910.1007/s10856-005-4713-8 ↗
8. Cooper JA, Lu HH, Ko FK, Freeman JW, Laurencin CT (2005) Biomaterials 26:152310.1016/j.biomaterials.2004.05.014 ↗
9. Chen VJ, Ma PX (2004) Biomaterials 25:206510.1016/j.biomaterials.2003.08.058 ↗
10. Robinson JR, Lee VHL (1987) Controlled drug delivery: fundamentals and applications, 2nd edn. Marcel Dekker, New York10.1201/b14193 ↗
11. Beckman EJ (2004) J Supercrit Fluids 28:12110.1016/S0896-8446(03)00029-9 ↗
12. Tomasko DL, Li H, Liu D, Han X, Wingert MJ, Lee LJ, Koelling KW (2003) Ind Eng Chem Res 42:643110.1021/ie030199z ↗
13. Cooper AI (2000) J Mater Chem 10:20710.1039/a906486i ↗
14. Kazarian SG (2000) Polymer Sci Ser 42:78
15. Cooper AI (2003) Adv Mater 15:104910.1002/adma.200300380 ↗
16. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R (1996) Biomaterials 17:141710.1016/0142-9612(96)87284-X ↗
17. Quirk RA, France RM, Shakesheff KM, Howdle SM (2004) Curr Opin Solid State Mater Sci 8:31310.1016/j.cossms.2003.12.004 ↗
18. Howdle SM, Watson MS, Whitaker MJ, Popov VK, Davies MC, Mandel FS, Don Wang J, Shakesheff KM (2001) Chem Commun 1:10910.1039/b008188o ↗
19. Xu Q, Chang Y (2004) J Appl Polym Sci 93:74210.1002/app.20539 ↗
20. Perrut M, Jung J, Leboeuf F (2005) Int J Pharm 288:1110.1016/j.ijpharm.2004.09.008 ↗
21. Kazarian SG, Martirosyan GG (2002) Int J Pharm 232:8110.1016/S0378-5173(01)00905-X ↗
22. Sheridan MH, Shea LD, Peters MC, Mooney DJ (2000) J Control Release 64:9110.1016/S0168-3659(99)00138-8 ↗
23. Kikic I, Vecchione F (2003) Curr Opin Solid State Mater Sci 7(4–5):39910.1016/j.cossms.2003.09.001 ↗
24. Woods HM, Silva MCG, Nouvel C, Shakesheff KM, Howdle SM (2004) J Mater Chem 14:166310.1039/b315262f ↗
25. Vega-González A, Domingo C, Elvira C, Subra P (2004) J Appl Polym Sci 91:242210.1002/app.13402 ↗
26. Reverchon E, Antonacci A (2007) J Supercrit Fluids 39:44410.1016/j.supflu.2006.03.005 ↗
27. Thies J, Müller BW (1998) Eur J Pharm Biopharm 45:6710.1016/S0939-6411(97)00124-0 ↗
28. Randolph TW, Randolph AD, Mebes M, Yeung S (1993) Biotechnol Prog 9:42910.1021/bp00022a010 ↗
29. Sproule TL, Lee JA, Li H, Lannutti JJ, Tomasko DL (2004) J Supercrit Fluids 28:24110.1016/S0896-8446(03)00044-5 ↗
30. Elvira C, Fanovich A, Fernandez M, Fraile J, San Roman J, Domingo C (2004) J Control Release 99:23110.1016/j.jconrel.2004.06.020 ↗
31. Muth O, Hirth Th, Vogel H (2000) J Supercrit Fluids 17:6510.1016/S0896-8446(99)00042-X ↗
32. Condo PD, Johnston KP (1992) Macromolecules 25:673010.1021/ma00050a057 ↗
33. Üzer S, Akman U, Hortaçsu Ö (2006) J Supercrit Fluids 38:11910.1016/j.supflu.2005.11.005 ↗
34. Kazarian S, Vincent MF, Bright FV, Liotta CL, Eckert CA (1996) J Am Chem Soc 118:172910.1021/ja950416q ↗
35. Wissinger RG, Paulatis ME (1987) J Polym Sci Part B Polym Phys 25:249710.1002/polb.1987.090251206 ↗
36. Pantoula M, Panayiotou C (2006) J Supercrit Fluids 37:25410.1016/j.supflu.2005.11.001 ↗
37. Goel SK, Beckman EJ (1994) Polym Eng Sci 34:114810.1002/pen.760341408 ↗
38. Barry JJA, Gidda HS, Scotchford CA, Howdle SM (2004) Biomaterials 25:355910.1016/j.biomaterials.2003.10.023 ↗
39. Krause B, Mettinkhof R, van der Vegt NFA, Wessling M (2001) Macromolecules 34:87410.1021/ma001291z ↗
40. Sheridan MH, Shea LD, Peters MC, Mooney DJ (2000) J Control Release 64:9110.1016/S0168-3659(99)00138-8 ↗
41. Takada M, Hasegawa S, Ohshima M (2001) Polym Eng Sci 41:193810.1002/pen.10890 ↗
42. Fischer EW, Sterzel HJ, Wegner G (1973) Colloid Polym Sci 251:1980
43. Nalawade SP, Picchioni F, Janssen LPBM (2006) Prog Polym Sci 31:1910.1016/j.progpolymsci.2005.08.002 ↗
44. Nauman EB, Ariyapadi MV, Balsara MV, Grocela TA, Furno JS, Liu SH, Mallikarjun R (1988) Chem Eng Commun 66:2910.1080/00986448808940259 ↗
45. Baldwin SP, Saltzman WM (1998) Adv Drug Deliv Rev 33:7110.1016/S0169-409X(98)00021-0 ↗
46. Karageorgiou V, Kaplan D (2005) Biomaterials 26:547410.1016/j.biomaterials.2005.02.002 ↗
47. Moroni L, de Wijn JR, Blitterswijk CA (2006) Biomaterials 27:97410.1016/j.biomaterials.2005.07.023 ↗
48. Bodmeier R, Wang H, Dixon DJ, Mawson S, Johnston KP (1995) Pharm Res 12:121110.1023/A:1016276329672 ↗
49. Elvassore N, Baggio M, Pallado P, Bertucco A (2001) Biotechnol Bioeng 73:44910.1002/bit.1079 ↗
50. Dixon DJ, Johnston KP (1993) J Appl Polym Sci 50:192910.1002/app.1993.070501110 ↗
51. Gentleman E, Lay AN, Dickerson DA, Nauman EA, Livesay GA, Dee KC (2003) Biomaterials 24:380510.1016/S0142-9612(03)00206-0 ↗